SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-23-005140
Filing Date
2023-07-07
Accepted
2023-07-07 17:28:20
Documents
15
Period of Report
2023-07-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K insd_8k.htm   iXBRL 8-K 31658
2 SHARE PURCHASE AGREEMENT insd_ex101.htm EX-10.1 57439
  Complete submission text file 0001477932-23-005140.txt   220400

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA insd-20230704.xsd EX-101.SCH 5753
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE insd-20230704_lab.xml EX-101.LAB 13667
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE insd-20230704_cal.xml EX-101.CAL 920
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insd-20230704_pre.xml EX-101.PRE 8612
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE insd-20230704_def.xml EX-101.DEF 2121
9 EXTRACTED XBRL INSTANCE DOCUMENT insd_8k_htm.xml XML 3385
Mailing Address 5500 NORTH SERVICE ROAD, SUITE 301 BURLINGTON A6 L7L 6W6
Business Address 5500 NORTH SERVICE ROAD, SUITE 301 BURLINGTON A6 L7L 6W6 800-542-8715
Instadose Pharma Corp. (Filer) CIK: 0001697587 (see all company filings)

IRS No.: 813599639 | State of Incorp.: NV | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 333-216292 | Film No.: 231077739
SIC: 2510 Household Furniture